Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | PDE4A | P27815 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.33 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2321352 | 1.00 | LMNA (0.41) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL2317860 | 1.00 | LMNA (0.41) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL2429499 | 1.00 | LMNA (0.41) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL3229856 | 1.00 | LMNA (0.41) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Sulfuric Acid SCHEMBL10602546 | 0.98 | LMNA (0.39) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL28503116 | 0.98 | LMNA (0.39) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Methane SCHEMBL17748249 | 0.96 | LMNA (0.38) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL3417631 | 0.84 | LMNA (0.39) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL3415482 | 0.84 | LMNA (0.39) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL3432829 | 0.84 | LMNA (0.39) | LMNAL3MBTL1TDP1KDM4EPDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1030 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4313016-A1 | METHODS AND COMPOSITIONS FOR TREATING LYSOSOMAL STORAGE DISORDERS | Sanford Health (US) | 2024-02-07 | — | — | EP | claimed |
| EP-3018177-B1 | STABILIZATION OF CARBON NANOTUBE COATINGS | BATTELLE MEMORIAL INSTITUTE (US) | 2023-08-02 | — | — | EP | claimed |
| EP-3011043-B1 | REVERSIBLE HEPARIN MOLECULES | UNIV NORTH CAROLINA CHAPEL HILL (US) | 2022-05-11 | — | — | EP | claimed |
| CN-105452479-B | Reversible heparin molecules | 北卡罗来纳大学查珀尔希尔分校 | 2021-05-18 | — | — | CN | claimed |
| EP-3793616-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF AAV | Voyager Therapeutics, Inc. (US) | 2021-03-24 | — | — | EP | claimed |
| US-10809212-B2 | Method for the analysis of glycosaminoglycans, and their derivatives and salts by nuclear magnetic resonance | LABORATORIOS FARMACÉUTICOS ROVI, S.A. (ES) | 2020-10-20 | — | — | US | claimed |
| US-20200271601-A1 | Method for the Analysis of Glycosaminoglycans, and Their Derivatives and Salts by Nuclear Magnetic Resonance | LABORATORIOS FARMACÉUTICOS ROVI, S.A. (ES) | 2020-08-27 | — | — | US | claimed |
| US-10705037-B2 | Method for the analysis of glycosaminoglycans, and their derivatives and salts by nuclear magnetic resonance | LABORATORIOS FARMACEUTICOS ROVI, S.A. (ES) | 2020-07-07 | — | — | US | claimed |
| US-20190154601-A1 | Method for the Analysis of Glycosaminoglycans, and Their Derivatives and Salts by Nuclear Magnetic Resonance | LABORATORIOS FARMACEUTICOS ROVI, S.A. (ES) | 2019-05-23 | — | — | US | claimed |
| EP-3273239-A1 | PROCEDURE OF ANALYSIS OF GLYCOSAMINOGLYCANS, HEPARINS AND THEIR DERIVATIVES BY NUCLEAR MAGNETIC RESONANCE | Laboratorios Farmacéuticos Rovi, S.A. (ES) | 2018-01-24 | — | — | EP | claimed |
| EP-0502496-B1 | Novel heparitinase, process for producing the same and bacteria producing the same | SEIKAGAKU KOGYO CO LTD (JP) | 1998-10-28 | — | — | EP | claimed |
| EP-0693553-B1 | Heparan sulfate 6-0-sulfotransferase | SEIKAGAKU KOGYO CO LTD (JP) | 1998-10-14 | — | — | EP | claimed |
| EP-0509517-B1 | Oligosaccharide having affinity for fibroblast growth factor and process for producing same | SEIKAGAKU KOGYO CO LTD (JP) | 1997-01-29 | — | — | EP | claimed |
| EP-0693553-A1 | Heparan sulfate 6-0-sulfotransferase | SEIKAGAKU KOGYO KABUSHIKI KAISHA (SEIKAGAKU CORPORATION) (JP) | 1996-01-24 | — | — | EP | claimed |
| EP-0348184-B1 | COSMETIC COMPOSITION | UNILEVER PLC (GB) | 1993-03-03 | — | — | EP | claimed |
| US-5185325-A | Topical for inducing hair growth; using aldono- or aldurono-monolactones as glycosaminoglycanase inhibitors; powders, shampoo, creams, lotions | CHESEBROUGH-POND'S USA CO., DIVISION OF CONOPCO, INC. (US) | 1993-02-09 | — | — | US | claimed |
| EP-0509517-A2 | Oligosaccharide having affinity for fibroblast growth factor and process for producing same | SEIKAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1992-10-21 | — | — | EP | claimed |
| EP-0348184-A2 | Cosmetic composition | UNILEVER PLC (GB) | 1989-12-27 | — | — | EP | claimed |
| EP-0014184-B2 | HEPARIN FRAGMENTS HAVING A SELECTIVE ANTICOAGULATION ACTIVITY AND PROCESS FOR THEIR PREPARATION | Kabi AB (SE) | 1989-10-18 | — | — | EP | claimed |
| EP-0014184-B1 | HEPARIN FRAGMENTS HAVING A SELECTIVE ANTICOAGULATION ACTIVITY AND PROCESS FOR THEIR PREPARATION | Kabi AB (SE) | 1984-08-15 | — | — | EP | claimed |